Market Research Logo

Influenza A Viral Infections Drug Development Pipeline Review, 2018

Influenza A Viral Infections Drug Development Pipeline Review, 2018

Summary


Influenza is an acute infection of the respiratory tract that predominately affects the nose, throat and bronchi, and less commonly the lungs. Influenza viruses have a single-stranded segmented RNA genome.

They belong to the family Orthomyxoviridae, and are categorized into three genera based on their core proteins - A, B and C. Influenza A and B viruses are responsible for the majority of symptomatic cases of influenza in humans.

Influenza A viruses can be further categorized based on their expression of two viral surface proteins: hemagglutinin (H) and neuraminidase (N). These viruses are known to have high mutation rates, with frequent changes to the viral protein structure.

The total number of products under development for influenza A H3N2, H1N1, H5N1 and H7N9 subtype infections is 54, 107, 58 and 31, respectively. Key companies operating in this pipeline space include Sanofi, Seqirus and NanoViricides.

This report “Influenza A Viral Infections Drug Development Pipeline Review, 2018” provides an overview of the pipeline landscape for influenza A viral infections. It comprehensively documents therapeutics under development for influenza A H3N2, H1N1, H5N1 and H7N9 subtype infections, and features dormant and discontinued products.

Scope

  • Which companies are the most active within the pipeline for influenza A viral infections?
  • Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened within this field?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration


  • Executive Summary
  • Introduction
    • Influenza A Viral Infections Report Coverage
    • Influenza A Virus, H3N2 Subtype Infections – Overview
    • Influenza A Virus, H1N1 Subtype Infections – Overview
    • Influenza A Virus, H5N1 Subtype Infections – Overview
    • Influenza A Virus, H7N9 Subtype Infections – Overview
  • Therapeutics Development
    • Influenza A Virus, H3N2 Subtype Infections
      • Pipeline Overview
        • Table Figure 1: Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections
      • Pipeline by Companies
        • Table Figure 2: Number of Products under Development by Companies, Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections
      • Pipeline by Universities/Institutes
        • Table Figure 3: Number of Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections
      • Products under Development by Companies
        • Table Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections
    • Influenza A Virus, H1N1 Subtype Infections
      • Pipeline Overview
        • Table Figure 4: Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections
        • Table Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections
      • Pipeline by Companies
        • Table Figure 5: Number of Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections
        • Table Number of Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections
      • Pipeline by Universities/Institutes
        • Table Figure 6: Number of Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections
        • Table Number of Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections
      • Products under Development by Companies
        • Table Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections
    • Influenza A Virus, H5N1 Subtype Infections
      • Pipeline Overview
        • Table Figure 7: Number of Products under Development for Influenza A Virus, H5N1 Subtype Infections
        • Table Number of Products under Development for Influenza A Virus, H5N1 Subtype Infections
      • Pipeline by Companies
        • Table Figure 8: Number of Products under Development by Companies, Influenza A Virus, H5N1 Subtype Infections
        • Table Number of Products under Development by Companies, Influenza A Virus, H5N1 Subtype Infections
      • Pipeline by Universities/Institutes
        • Table Figure 9: Number of Products under Development by Universities/Institutes, Influenza A Virus, H5N1 Subtype Infections
        • Table Number of Products under Development by Universities/Institutes, Influenza A Virus, H5N1 Subtype Infections
      • Products under Development by Companies
        • Table Products under Development by Companies, Influenza A Virus, H5N1 Subtype Infections
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes, Influenza A Virus, H5N1 Subtype Infections
    • Influenza A Virus, H7N9 Subtype Infections
      • Pipeline Overview
        • Table Figure 10: Number of Products under Development for Influenza A Virus, H7N9 Subtype Infections
        • Table Number of Products under Development for Influenza A Virus, H7N9 Subtype Infections
      • Pipeline by Companies
        • Table Figure 11: Number of Products under Development by Companies, Influenza A Virus, H7N9 Subtype Infections
        • Table Number of Products under Development by Companies, Influenza A Virus, H7N9 Subtype Infections
      • Pipeline by Universities/Institutes
        • Table Figure 12: Number of Products under Development by Universities/Institutes, Influenza A Virus, H7N9 Subtype Infections
        • Table Number of Products under Development by Universities/Institutes, Influenza A Virus, H7N9 Subtype Infections
      • Products under Development by Companies
        • Table Products under Development by Companies, Influenza A Virus, H7N9 Subtype Infections
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes, Influenza A Virus, H7N9 Subtype Infections
  • Therapeutics Assessment
    • Influenza A Virus, H3N2 Subtype Infections
      • Assessment by Target
        • Table Figure 13: Number of Products by Top 10 Targets, Influenza A Virus, H3N2 Subtype Infections
        • Table Figure 14: Number of Products by Stage and Top 10 Targets, Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products by Stage and Target, Influenza A Virus, H3N2 Subtype Infections
      • Assessment by Mechanism of Action
        • Table Figure 15: Number of Products by Top 10 Mechanism of Actions, Influenza A Virus, H3N2 Subtype Infections
        • Table Figure 16: Number of Products by Stage and Top 10 Mechanism of Actions, Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products by Stage and Mechanism of Action, Influenza A Virus, H3N2 Subtype Infections
      • Assessment by Route of Administration
        • Table Figure 17: Number of Products by Routes of Administration, Influenza A Virus, H3N2 Subtype Infections
        • Table Figure 18: Number of Products by Stage and Routes of Administration, Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products by Stage and Route of Administration, Influenza A Virus, H3N2 Subtype Infections
      • Assessment by Molecule Type
        • Table Figure 19: Number of Products by Top 10 Molecule Types, Influenza A Virus, H3N2 Subtype Infections
        • Table Figure 20: Number of Products by Stage and Top 10 Molecule Types, Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products by Stage and Molecule Type, Influenza A Virus, H3N2 Subtype Infections
    • Influenza A Virus, H1N1 Subtype Infections
      • Assessment by Target
        • Table Figure 21: Number of Products by Top 10 Targets, Influenza A Virus, H1N1 Subtype Infections
        • Table Figure 22: Number of Products by Stage and Top 10 Targets, Influenza A Virus, H1N1 Subtype Infections
        • Table Number of Products by Stage and Target, Influenza A Virus, H1N1 Subtype Infections
      • Assessment by Mechanism of Action
        • Table Figure 23: Number of Products by Top 10 Mechanism of Actions, Influenza A Virus, H1N1 Subtype Infections
        • Table Figure 24: Number of Products by Stage and Top 10 Mechanism of Actions, Influenza A Virus, H1N1 Subtype Infections
        • Table Number of Products by Stage and Mechanism of Action, Influenza A Virus, H1N1 Subtype Infections
      • Assessment by Route of Administration
        • Table Figure 25: Number of Products by Top 10 Routes of Administration, Influenza A Virus, H3N2 Subtype Infections
        • Table Figure 26: Number of Products by Stage and Top 10 Routes of Administration, Influenza A Virus, H3N2 Subtype Infections
        • Table Number of Products by Stage and Route of Administration, Influenza A Virus, H1N1 Subtype Infections
      • Assessment by Molecule Type
        • Table Figure 27: Number of Products by Top 10 Molecule Types, Influenza A Virus, H1N1 Subtype Infections
        • Table Figure 28: Number of Products by Stage and Top 10 Molecule Types, Influenza A Virus, H1N1 Subtype Infections
        • Table Number of Products by Stage and Molecule Type, Influenza A Virus, H1N1 Subtype Infections
    • Influenza A Virus, H5N1 Subtype Infections
      • Assessment by Target
        • Table Figure 29: Number of Products by Top 10 Targets, Influenza A Virus, H5N1 Subtype Infections
        • Table Figure 30: Number of Products by Stage and Top 10 Targets, Influenza A Virus, H5N1 Subtype Infections
        • Table Number of Products by Stage and Target, Influenza A Virus, H5N1 Subtype Infections
      • Assessment by Mechanism of Action
        • Table Figure 31: Number of Products by Top 10 Mechanism of Actions, Influenza A Virus, H5N1 Subtype Infections
        • Table Figure 32: Number of Products by Stage and Top 10 Mechanism of Actions, Influenza A Virus, H5N1 Subtype Infections
        • Table Number of Products by Stage and Mechanism of Action, Influenza A Virus, H5N1 Subtype Infections
      • Assessment by Route of Administration
        • Table Figure 33: Number of Products by Routes of Administration, Influenza A Virus, H5N1 Subtype Infections
        • Table Figure 34: Number of Products by Stage and Routes of Administration, Influenza A Virus, H5N1 Subtype Infections
        • Table Number of Products by Stage and Route of Administration, Influenza A Virus, H5N1 Subtype Infections
      • Assessment by Molecule Type
        • Table Figure 35: Number of Products by Top 10 Molecule Types, Influenza A Virus, H5N1 Subtype Infections
        • Table Figure 36: Number of Products by Stage and Top 10 Molecule Types, Influenza A Virus, H5N1 Subtype Infections
        • Table Number of Products by Stage and Molecule Type, Influenza A Virus, H5N1 Subtype Infections
    • Influenza A Virus, H7N9 Subtype Infections
      • Assessment by Target
        • Table Figure 37: Number of Products by Targets, Influenza A Virus, H7N9 Subtype Infections
        • Table Figure 38: Number of Products by Stage and Targets, Influenza A Virus, H7N9 Subtype Infections
        • Table Number of Products by Stage and Target, Influenza A Virus, H7N9 Subtype Infections
      • Assessment by Mechanism of Action
        • Table Figure 39: Number of Products by Mechanism of Actions, Influenza A Virus, H7N9 Subtype Infections
        • Table Figure 40: Number of Products by Stage and Mechanism of Actions, Influenza A Virus, H7N9 Subtype Infections
        • Table Number of Products by Stage and Mechanism of Action, Influenza A Virus, H7N9 Subtype Infections
      • Assessment by Route of Administration
        • Table Figure 41: Number of Products by Routes of Administration, Influenza A Virus, H7N9 Subtype Infections
        • Table Figure 42: Number of Products by Stage and Routes of Administration, Influenza A Virus, H7N9 Subtype Infections
        • Table Number of Products by Stage and Route of Administration, Influenza A Virus, H7N9 Subtype Infections
      • Assessment by Molecule Type
        • Table Figure 43: Number of Products by Molecule Types, Influenza A Virus, H7N9 Subtype Infections
        • Table Figure 44: Number of Products by Stage and Molecule Types, Influenza A Virus, H7N9 Subtype Infections
        • Table Number of Products by Stage and Molecule Type, Influenza A Virus, H7N9 Subtype Infections
  • Companies Involved in Therapeutics Development
    • Influenza A Virus, H3N2 Subtype Infections
      • AbbVie Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by AbbVie Inc
      • Adimmune Corp
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Adimmune Corp
      • Aphios Corp
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Aphios Corp
      • AusBio Ltd
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by AusBio Ltd
      • BioCryst Pharmaceuticals Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by BioCryst Pharmaceuticals Inc
      • BiondVax Pharmaceuticals Ltd
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by BiondVax Pharmaceuticals Ltd
      • Cadila Healthcare Ltd
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Cadila Healthcare Ltd
      • Celltrion Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Celltrion Inc
      • Emergent BioSolutions Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Emergent BioSolutions Inc
      • FluGen Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by FluGen Inc
      • Inovio Pharmaceuticals Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Inovio Pharmaceuticals Inc
      • Jiangsu Kanion Pharmaceutical Co Ltd
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd
      • Johnson & Johnson
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Johnson & Johnson
      • Medicago Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Medicago Inc
      • MedImmune LLC
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by MedImmune LLC
      • Mucosis BV (Inactive)
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Mucosis BV (Inactive)
      • NanoViricides Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by NanoViricides Inc
      • Novavax Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Novavax Inc
      • OPKO Health Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by OPKO Health Inc
      • Sanofi
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Sanofi
      • Sanofi Pasteur SA
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Sanofi Pasteur SA
      • Sarepta Therapeutics Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by Sarepta Therapeutics Inc
      • SK Chemicals Co Ltd
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by SK Chemicals Co Ltd
      • VBI Vaccines Inc
        • Table Influenza A Virus, H3N2 Subtype Infections – Pipeline by VBI Vaccines Inc
    • Influenza A Virus, H1N1 Subtype Infections
      • AbbVie Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by AbbVie Inc
      • Adimmune Corp
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Adimmune Corp
      • Akshaya Bio Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Akshaya Bio Inc
      • Altimmune Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Altimmune Inc
      • Antigen Express Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Antigen Express Inc
      • Beijing Minhai Biotechnology Co Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Beijing Minhai Biotechnology Co Ltd
      • BioCryst Pharmaceuticals Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by BioCryst Pharmaceuticals Inc
      • Cadila Healthcare Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Cadila Healthcare Ltd
      • CEL-SCI Corp
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by CEL-SCI Corp
      • Cilian AG
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Cilian AG
      • Cocrystal Pharma Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Cocrystal Pharma Inc
      • ContraFect Corp
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by ContraFect Corp
      • Curevac AG
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Curevac AG
      • Emergent BioSolutions Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Emergent BioSolutions Inc
      • EpiVax Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by EpiVax Inc
      • Etubics Corp
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Etubics Corp
      • Gemmus Pharma Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Gemmus Pharma Inc
      • Genentech Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Genentech Inc
      • GlaxoSmithKline Plc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by GlaxoSmithKline Plc
      • iBio Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by iBio Inc
      • Inovio Pharmaceuticals Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Inovio Pharmaceuticals Inc
      • Jiangsu Kanion Pharmaceutical Co Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd
      • Johnson & Johnson
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Johnson & Johnson
      • Karyopharm Therapeutics Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Karyopharm Therapeutics Inc
      • Kineta Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Kineta Inc
      • Kyowa Hakko Kirin Co Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Kyowa Hakko Kirin Co Ltd
      • Lakewood-Amedex Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Lakewood-Amedex Inc
      • Medicago Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Medicago Inc
      • MedImmune LLC
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by MedImmune LLC
      • Microbiotix Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Microbiotix Inc
      • Mucosis BV (Inactive)
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Mucosis BV (Inactive)
      • NanoViricides Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by NanoViricides Inc
      • Novavax Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Novavax Inc
      • OPKO Health Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by OPKO Health Inc
      • PeptiDream Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by PeptiDream Inc
      • Recce Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Recce Ltd
      • Sanofi
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Sanofi
      • Sanofi Pasteur SA
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Sanofi Pasteur SA
      • Sarepta Therapeutics Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Sarepta Therapeutics Inc
      • SK Chemicals Co Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by SK Chemicals Co Ltd
      • TechnoVax Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by TechnoVax Inc
      • Touchlight Genetics Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Touchlight Genetics Ltd
      • Vaccibody AS
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Vaccibody AS
      • Vaxart Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Vaxart Inc
      • VirionHealth Ltd
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by VirionHealth Ltd
      • Visterra Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Visterra Inc
      • Vivaldi Biosciences Inc
        • Table Influenza A Virus, H1N1 Subtype Infections – Pipeline by Vivaldi Biosciences Inc
    • Influenza A Virus, H5N1 Subtype Infections
      • Akshaya Bio Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Akshaya Bio Inc
      • Altimmune Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Altimmune Inc
      • Antigen Express Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Antigen Express Inc
      • Aphios Corp
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Aphios Corp
      • AusBio Ltd
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by AusBio Ltd
      • BiondVax Pharmaceuticals Ltd
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by BiondVax Pharmaceuticals Ltd
      • CEL-SCI Corp
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by CEL-SCI Corp
      • Cocrystal Pharma Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Cocrystal Pharma Inc
      • Curevac AG
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Curevac AG
      • Gemmus Pharma Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Gemmus Pharma Inc
      • GlaxoSmithKline Plc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by GlaxoSmithKline Plc
      • Hemispherx Biopharma Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Hemispherx Biopharma Inc
      • iBio Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by iBio Inc
      • Inovio Pharmaceuticals Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Inovio Pharmaceuticals Inc
      • Johnson & Johnson
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Johnson & Johnson
      • Karyopharm Therapeutics Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Karyopharm Therapeutics Inc
      • Kineta Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Kineta Inc
      • Lakewood-Amedex Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Lakewood-Amedex Inc
      • Medicago Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Medicago Inc
      • Medigen Vaccine Biologics Corp
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Medigen Vaccine Biologics Corp
      • Microbiotix Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Microbiotix Inc
      • NanoBio Corp
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by NanoBio Corp
      • NanoViricides Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by NanoViricides Inc
      • Ology Bioservices Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Ology Bioservices Inc
      • OPKO Health Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by OPKO Health Inc
      • PaxVax Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by PaxVax Inc
      • PeptiDream Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by PeptiDream Inc
      • Shionogi & Co Ltd
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Shionogi & Co Ltd
      • TechnoVax Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by TechnoVax Inc
      • Vaxart Inc
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Vaxart Inc
      • Vaxine Pty Ltd
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by Vaxine Pty Ltd
      • VirionHealth Ltd
        • Table Influenza A Virus, H5N1 Subtype Infections – Pipeline by VirionHealth Ltd
    • Influenza A Virus, H7N9 Subtype Infections
      • AusBio Ltd
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by AusBio Ltd
      • Beijing Minhai Biotechnology Co Ltd
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Beijing Minhai Biotechnology Co Ltd
      • Cocrystal Pharma Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Cocrystal Pharma Inc
      • EpiVax Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by EpiVax Inc
      • Genentech Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Genentech Inc
      • iBio Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by iBio Inc
      • Inovio Pharmaceuticals Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Inovio Pharmaceuticals Inc
      • Karyopharm Therapeutics Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Karyopharm Therapeutics Inc
      • Medicago Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Medicago Inc
      • Medigen Vaccine Biologics Corp
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Medigen Vaccine Biologics Corp
      • Moderna Therapeutics Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Moderna Therapeutics Inc
      • NanoViricides Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by NanoViricides Inc
      • Ology Bioservices Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Ology Bioservices Inc
      • Sanofi Pasteur SA
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Sanofi Pasteur SA
      • Shionogi & Co Ltd
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Shionogi & Co Ltd
      • VirionHealth Ltd
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by VirionHealth Ltd
      • Visterra Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Visterra Inc
      • Vivaldi Biosciences Inc
        • Table Influenza A Virus, H7N9 Subtype Infections – Pipeline by Vivaldi Biosciences Inc
  • Dormant Projects
    • Influenza A Virus, H3N2 Subtype Infections
      • Table Influenza A Virus, H3N2 Subtype Infections – Dormant Projects
    • Influenza A Virus, H1N1 Subtype Infections
      • Table Influenza A Virus, H1N1 Subtype Infections – Dormant Projects
    • Influenza A Virus, H5N1 Subtype Infections
      • Table Influenza A Virus, H5N1 Subtype Infections – Dormant Projects
    • Influenza A Virus, H7N9 Subtype Infections
      • Table Influenza A Virus, H7N9 Subtype Infections – Dormant Projects
  • Discontinued Products
    • Influenza A Virus, H3N2 Subtype Infections
      • Table Influenza A Virus, H3N2 Subtype Infections – Discontinued Products
    • Influenza A Virus, H1N1 Subtype Infections
      • Table Influenza A Virus, H1N1 Subtype Infections – Discontinued Products
    • Influenza A Virus, H5N1 Subtype Infections
      • Table Influenza A Virus, H5N1 Subtype Infections – Discontinued Products
  • Product Development Milestones
    • Influenza A Virus, H3N2 Subtype Infections
      • Featured News & Press Releases
    • Influenza A Virus, H1N1 Subtype Infections
      • Featured News & Press Releases
    • Influenza A Virus, H5N1 Subtype Infections
      • Featured News & Press Releases
    • Influenza A Virus, H7N9 Subtype Infections
      • Featured News & Press Releases
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report